Investigations

GRABAR LAW OFFICE INVESTIGATES CLAIMS AGAINST OFFICERS AND DIRECTORS OF FMC CORPORATION (NYSE: FMC)

FMC Corporation (NYSE: FMC) sells diamide products. The Company acquired the patented diamides from DuPont de Nemours, Inc. in 2017 and currently brands them in the U.S. as Rynaxypyr and Cyazypyr.

A recently filed securities fraud class action complaint alleges that FMC Corporation (NYSE: FMC), via certain of its officers and directors, made materially false and/or misleading statements and failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that FMC failed to disclose to investors that: (1) the diminishment of patent protection for FMC's flagship products following legal defeats in key markets including India, China, and Brazil had opened the door to increased competition from generics; (2) the Company repeatedly mislead investors about the status of such proceedings and falsely claimed that it did not and would not face generic competition in key markets until 2026 at the earliest; and (3) because of these issues Defendant's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Current FMC shareholders who have held FMC stock since prior to November 2, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award at no cost to them whatsoever.

If you would like to learn more about this matter, you are encouraged to contact us at jgrabar@grabarlaw.com, or call 267-507-6085.

Please enter your name.
Please enter a valid phone number.
Please enter a message.

  • Join This Action

  • Alternatively, you may upload your transactions using the upload button below or email them to jgrabar@grabarlaw.com. *

  • Drop files here or
    Max. file size: 100 MB.
    • Signed pursuant to California Civil Code Section 1633.1, et seq. and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.
    • Date of signing: *

    • MM slash DD slash YYYY
    • This field is for validation purposes and should be left unchanged.